Neil Leaver

423 total citations
25 papers, 338 citations indexed

About

Neil Leaver is a scholar working on Surgery, Transplantation and Pharmacology. According to data from OpenAlex, Neil Leaver has authored 25 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Transplantation and 6 papers in Pharmacology. Recurrent topics in Neil Leaver's work include Transplantation: Methods and Outcomes (11 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Neil Leaver is often cited by papers focused on Transplantation: Methods and Outcomes (11 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Neil Leaver collaborates with scholars based in United Kingdom, Poland and United States. Neil Leaver's co-authors include Nicholas R. Banner, Haifa Lyster, Magdi H. Yacoub, Gitika Panicker, A. E. Johnston, Ryszard T. Smoleński, Marlene L. Rose, H. Anne Simmonds, Katarzyna Prusik and Marek Szołkiewicz and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Transplantation and Nephrology Dialysis Transplantation.

In The Last Decade

Neil Leaver

24 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Leaver United Kingdom 13 99 95 58 53 52 25 338
Anja Bienholz Germany 14 54 0.5× 76 0.8× 91 1.6× 17 0.3× 37 0.7× 33 399
Péter Lipták Slovakia 8 129 1.3× 74 0.8× 24 0.4× 17 0.3× 36 0.7× 25 296
Antoney Ferrey United States 11 44 0.4× 53 0.6× 29 0.5× 22 0.4× 89 1.7× 28 434
I Lampreabe Spain 11 183 1.8× 180 1.9× 62 1.1× 39 0.7× 13 0.3× 25 457
William McGhee United States 9 160 1.6× 166 1.7× 37 0.6× 47 0.9× 20 0.4× 17 356
Joshua L. Rein United States 9 61 0.6× 78 0.8× 24 0.4× 47 0.9× 31 0.6× 21 384
M Gürsoy Türkiye 10 55 0.6× 94 1.0× 83 1.4× 11 0.2× 11 0.2× 21 379
I. Umbro Italy 13 129 1.3× 241 2.5× 133 2.3× 55 1.0× 16 0.3× 40 532
Pengmei Li China 11 37 0.4× 38 0.4× 43 0.7× 20 0.4× 30 0.6× 46 283
Thomas Weinreich Germany 13 15 0.2× 54 0.6× 31 0.5× 51 1.0× 50 1.0× 27 376

Countries citing papers authored by Neil Leaver

Since Specialization
Citations

This map shows the geographic impact of Neil Leaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Leaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Leaver more than expected).

Fields of papers citing papers by Neil Leaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Leaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Leaver. The network helps show where Neil Leaver may publish in the future.

Co-authorship network of co-authors of Neil Leaver

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Leaver. A scholar is included among the top collaborators of Neil Leaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Leaver. Neil Leaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leaver, Neil, et al.. (2018). Children with cystic fibrosis demonstrate no respiratory immunological, infective or physiological, consequences of vitamin D deficiency. Journal of Cystic Fibrosis. 17(5). 657–665. 13 indexed citations
2.
Lyster, Haifa, Olaf Maunz, Diana García Sáez, et al.. (2017). Potential Posaconazole Sequestration During Extracorporeal Membrane Oxygentation: Results from an Ex-Vivo Experiment. The Journal of Heart and Lung Transplantation. 36(4). S26–S26.
3.
Antosiewicz, Jędrzej, Jakub Kortas, Katarzyna Prusik, et al.. (2015). Effect of Nordic Walking training on iron metabolism in elderly women. Clinical Interventions in Aging. 10. 1889–1889. 32 indexed citations
4.
Thakuria, Louit, Paul Rogers, Simona Soresi, et al.. (2015). A pharmacokinetic analysis of posaconazole oral suspension in the serum and alveolar compartment of lung transplant recipients. International Journal of Antimicrobial Agents. 47(1). 69–76. 15 indexed citations
5.
Girdlestone, John, Jeffrey Pido-Lopez, Jian‐Guo Chai, et al.. (2015). Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs. Cytotherapy. 17(9). 1188–1199. 26 indexed citations
6.
Leaver, Neil, et al.. (2013). Milrinone in Advanced Heart Failure. Angiology. 65(4). 343–349. 7 indexed citations
7.
Lyster, Haifa, Neil Leaver, Iman Hamour, Andrew Palmer, & N.R. Banner. (2009). Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens. Nephrology Dialysis Transplantation. 24(12). 3872–3875. 5 indexed citations
8.
Taegtmeyer, Anne B., John P. Smith, Neil Leaver, et al.. (2009). ATP-Binding Cassette Subfamily B Member 1 Polymorphisms Do Not Determine Cyclosporin Exposure, Acute Rejection or Nephrotoxicity After Heart Transplantation. Transplantation. 89(1). 75–82. 12 indexed citations
9.
Lyster, Haifa, Gitika Panicker, Neil Leaver, & Nicholas R. Banner. (2004). Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation. Transplantation Proceedings. 36(10). 3167–3170. 36 indexed citations
10.
Banner, Nicholas R., Olivier David, Neil Leaver, et al.. (2002). Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Transplant International. 15(12). 649–654. 17 indexed citations
11.
Słomińska, Ewa M., Ryszard T. Smoleński, Marek Szołkiewicz, et al.. (2002). Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure. Molecular and Cellular Biochemistry. 231(1-2). 83–88. 33 indexed citations
12.
Banner, Nicholas R., Olivier J. David, Neil Leaver, et al.. (2002). Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery. Transplant International. 15(12). 649–654. 15 indexed citations
13.
Leaver, Neil, et al.. (2001). Coadministration of itraconazole and tacrolimus after thoracic organ transplantation. Transplantation Proceedings. 33(1-2). 1600–1602. 21 indexed citations
14.
Mikhail, Ghada, et al.. (1998). Comparison of Neoral and Sandimmun Cyclosporines for De Novo Lung Transplantation in Cystic Fibrosis Patients. Transplantation Proceedings. 30(4). 1510–1511. 2 indexed citations
15.
Walker, S., et al.. (1998). Effect of Sandimmune Cyclosporine on Renal Blood Flow and Function in Heart Transplant Recipients. Transplantation Proceedings. 30(4). 1147–1148. 4 indexed citations
16.
Mikhail, Ghada, Neil Leaver, Paul Rogers, et al.. (1997). An investigation of the pharmacokinetics, toxicity, and clinical efficacy of neoral cyclosporin in cystic fibrosis patients. Transplantation Proceedings. 29(1-2). 599–601. 10 indexed citations
17.
Rose, Marlene L., et al.. (1995). A pharmacokinetic comparison of cyclosporin oral solution and cyclosporin capsules in heart and lung transplant recipients. Transplant International. 8(1). 35–40. 2 indexed citations
18.
Tsang, Victor, et al.. (1994). Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis. European Journal of Clinical Pharmacology. 46(3). 261–5. 22 indexed citations
19.
Mikhail, Ghada, et al.. (1994). Use of Neoral in heart transplant recipients.. PubMed. 26(5). 2985–7. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026